ENTRADA THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $298.7M | $291.1M |
| FY2022 | — | $212.6M | $45.2M |
| FY2023 | — | $242.4M | $67.6M |
| FY2024 | — | $428.7M | $101.2M |
| FY2025 | — | $306.1M | $90.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $298.7M | $291.1M |
| FY2022 | — | $212.6M | $45.2M |
| FY2023 | — | $242.4M | $67.6M |
| FY2024 | — | $428.7M | $101.2M |
| FY2025 | — | $306.1M | $90.4M |